article thumbnail

Atrial Fibrillation Ablation in Congenital Heart Disease: Therapeutic Challenges and Future Perspectives

Journal of the American Heart Association

The increasing prevalence of atrial fibrillation (AF) in adults with congenital heart disease raises significant questions regarding its management. The unique underlying anatomic and physiological background further adds to the difficulty in eliminating the AF burden in these patients.

article thumbnail

Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease: Updates in Neuroprotection, Risk-Stratification, Evaluation, and Management: A Scientific Statement From the American Heart Association

Circulation

Over the past decade, new research has advanced scientific knowledge of neurodevelopmental trajectories, factors that increase neurodevelopmental risk, and neuroprotective strategies for individuals with congenital heart disease.

article thumbnail

Time to childbirth and assisted reproductive treatment in women with congenital heart disease

Open Heart

Objective To investigate the time to first childbirth and to compare the prevalence of assisted reproductive treatment (ART) in women with congenital heart disease (CHD) compared with women without CHD. ART was more common in women with CHD, but disease severity did not influence the need for ART.

article thumbnail

The mechanics of congenital heart disease: from a morphological trait to the functional echocardiographic evaluation

Frontiers in Cardiovascular Medicine

Advances in pediatric cardiac surgery have resulted in a recent growing epidemic of children and young adults with congenital heart diseases (CHDs). In these patients, congenital defects themselves, surgical operations and remaining lesions may alter cardiac anatomy and impact the mechanical performance of both ventricles.

article thumbnail

COVID-19 in congenital heart disease (COaCHeD) study

Open Heart

Congenital heart disease (CHD) is likely to increase vulnerability and understanding the predictors of adverse outcomes is key to optimising care. Objective Ascertain the impact of COVID-19 on people with CHD and define risk factors for adverse outcomes.

article thumbnail

Environmental Exposures and Pediatric Cardiology: A Scientific Statement From the American Heart Association

Circulation

Emerging evidence suggests that environmental exposures in early life may be key risk factors for cardiovascular conditions across the life span.

article thumbnail

Waitlist Outcomes in Candidates With Rare Causes of Heart Failure After Implementation of the 2018 French Heart Allocation Scheme

Circulation: Heart Failure

for patients with hypertrophic cardiomyopathy, RCM, congenital heart disease, and other cardiomyopathies). 2.58];P=0.94; congenital heart disease, 1.82 [95% CI, 0.78–4.26];P=0.17). 1.58];P=0.23; congenital heart disease: HR, 0.76 [95% CI, 0.53–1.09];P=0.14). and 0.40, respectively).